Ibrutinib for Mantle Cell Lymphoma at First Relapse
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Haematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ibrutinib for Mantle Cell Lymphoma at First Relapse: A United Kingdom Real-World Analysis of Outcomes In 211 Patients
Br. J. Haematol 2021 Feb 23;[EPub Ahead of Print], R McCulloch, D Lewis, N Crosbie, TA Eyre, S Bolam, A Arasaretnam, T Creasey, H Goradia, A McMillan, S Dawi, S Harrison, O Miles, A Robinson, D Dutton, MR Wilson, P McKay, G Follows, N Phillips, R Patmore, J Lambert, M Bishton, W Osborne, R Johnston, AA Kirkwood, S RuleFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.